July 18, 2019 / 1:04 PM / a month ago

BRIEF-Novartis CEO Says U.S. Gov't Policy Environment Very Fluid

July 18 (Reuters) - Novartis AG:

* NOVARTIS CEO SAYS PLANS TO INITIATE DISCUSSIONS WITH FDA OVER INTRATHECAL ADMINISTRATION OF ZOLGENSMA LATER THIS YEAR

* NOVARTIS CFO SAYS PROFITABILITY BENEFITED IN H1 FROM VALSARTAN SUPPLY SHORTAGE

* NOVARTIS CEO SAYS U.S. GOVERNMENT POLICY ENVIRONMENT "VERY FLUID" REGARDING DRUG PRICING AFTER TRUMP ADMINISTRATION DROPS REBATE RULE

* NOVARTIS DRUG DIVISION CHIEF SAYS CONFIDENT ABOUT MS DRUG MAYZENT'S LONGTERM POTENTIAL, BUT SAYS 'THIS YEAR IS ALL ABOUT EDUCATION" AND IDENTIFYING PATIENTS Further company coverage: (Reporting by John Miller)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below